Association between white matter lesions and cerebral Aβ burden.

INTRODUCTION:White matter lesions (WMLs), detected as hyperintensities on T2-weighted MRI, represent small vessel disease in the brain and are considered a potential risk factor for memory and cognitive impairment in older adults. The purpose of this study was to evaluate the association between WML...

Full description

Bibliographic Details
Main Authors: Hyon-Ah Yi, Kyoung Sook Won, Hyuk Won Chang, Hae Won Kim
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC6152974?pdf=render
_version_ 1818338406589005824
author Hyon-Ah Yi
Kyoung Sook Won
Hyuk Won Chang
Hae Won Kim
author_facet Hyon-Ah Yi
Kyoung Sook Won
Hyuk Won Chang
Hae Won Kim
author_sort Hyon-Ah Yi
collection DOAJ
description INTRODUCTION:White matter lesions (WMLs), detected as hyperintensities on T2-weighted MRI, represent small vessel disease in the brain and are considered a potential risk factor for memory and cognitive impairment in older adults. The purpose of this study was to evaluate the association between WMLs and cerebral amyloid-β (Aβ) burden in patients with cognitive impairment. METHODS:A total of 83 patients with cognitive impairment, who underwent brain MRI and F-18 florbetaben PET, were included prospectively: 19 patients were cognitively unimpaired, 30 exhibited mild cognitive impairment (MCI), and 34 exhibited dementia. The Fazekas scale was used to quantify WMLs on T2-weighted brain MR images. Cerebral Aβ burden was quantitatively estimated using volume-of-interest analysis. Differences in cerebral Aβ burden were evaluated between low-WML (Fazekas scale ≤1) and high-WML (Fazekas scale ≥2) groups. The relationship between the Fazekas rating and cerebral Aβ burden was evaluated using linear regression analysis after adjusting for age and sex. RESULTS:In the overall cohort, the high-WML group exhibited significantly higher Aβ burden compared with the low-WML group (P = 0.011) and cerebral Aβ burden was positively correlated with Fazekas rating (β = 0.299, P = 0.006). In patients with MCI, the high-WML group exhibited significantly higher Aβ burden compared with the low-WML group (P = 0.019) and cerebral Aβ burden was positively correlated with Fazekas rating (β = 0.517, P = 0.003). CONCLUSION:The presence of WMLs was associated with cerebral Aβ burden in patients with MCI. Our findings suggest that small vessel disease in the brain is related to Alzheimer's disease pathology.
first_indexed 2024-12-13T15:10:36Z
format Article
id doaj.art-eb48ad6319e3453db0d7d6113e7ae72c
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-13T15:10:36Z
publishDate 2018-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-eb48ad6319e3453db0d7d6113e7ae72c2022-12-21T23:40:54ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01139e020431310.1371/journal.pone.0204313Association between white matter lesions and cerebral Aβ burden.Hyon-Ah YiKyoung Sook WonHyuk Won ChangHae Won KimINTRODUCTION:White matter lesions (WMLs), detected as hyperintensities on T2-weighted MRI, represent small vessel disease in the brain and are considered a potential risk factor for memory and cognitive impairment in older adults. The purpose of this study was to evaluate the association between WMLs and cerebral amyloid-β (Aβ) burden in patients with cognitive impairment. METHODS:A total of 83 patients with cognitive impairment, who underwent brain MRI and F-18 florbetaben PET, were included prospectively: 19 patients were cognitively unimpaired, 30 exhibited mild cognitive impairment (MCI), and 34 exhibited dementia. The Fazekas scale was used to quantify WMLs on T2-weighted brain MR images. Cerebral Aβ burden was quantitatively estimated using volume-of-interest analysis. Differences in cerebral Aβ burden were evaluated between low-WML (Fazekas scale ≤1) and high-WML (Fazekas scale ≥2) groups. The relationship between the Fazekas rating and cerebral Aβ burden was evaluated using linear regression analysis after adjusting for age and sex. RESULTS:In the overall cohort, the high-WML group exhibited significantly higher Aβ burden compared with the low-WML group (P = 0.011) and cerebral Aβ burden was positively correlated with Fazekas rating (β = 0.299, P = 0.006). In patients with MCI, the high-WML group exhibited significantly higher Aβ burden compared with the low-WML group (P = 0.019) and cerebral Aβ burden was positively correlated with Fazekas rating (β = 0.517, P = 0.003). CONCLUSION:The presence of WMLs was associated with cerebral Aβ burden in patients with MCI. Our findings suggest that small vessel disease in the brain is related to Alzheimer's disease pathology.http://europepmc.org/articles/PMC6152974?pdf=render
spellingShingle Hyon-Ah Yi
Kyoung Sook Won
Hyuk Won Chang
Hae Won Kim
Association between white matter lesions and cerebral Aβ burden.
PLoS ONE
title Association between white matter lesions and cerebral Aβ burden.
title_full Association between white matter lesions and cerebral Aβ burden.
title_fullStr Association between white matter lesions and cerebral Aβ burden.
title_full_unstemmed Association between white matter lesions and cerebral Aβ burden.
title_short Association between white matter lesions and cerebral Aβ burden.
title_sort association between white matter lesions and cerebral aβ burden
url http://europepmc.org/articles/PMC6152974?pdf=render
work_keys_str_mv AT hyonahyi associationbetweenwhitematterlesionsandcerebralabburden
AT kyoungsookwon associationbetweenwhitematterlesionsandcerebralabburden
AT hyukwonchang associationbetweenwhitematterlesionsandcerebralabburden
AT haewonkim associationbetweenwhitematterlesionsandcerebralabburden